» Articles » PMID: 33737688

Evaluation of Moxifloxacin-induced Cytotoxicity on Human Corneal Endothelial Cells

Overview
Journal Sci Rep
Specialty Science
Date 2021 Mar 19
PMID 33737688
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Moxifloxacin hydrochloride (MXF) is widely used for the prevention of bacterial endophthalmitis after intraocular surgeries. However, the safety issue of intracameral injection of MXF for human corneal endothelial cells (HCECs) is still debatable. In this study, we investigated concentration-dependent cytotoxicity (0.05-1 mg/ml) of MXF for immortalized HCECs (B4G12 cell) and the underlying mechanism. Reactive oxygen generation (ROS) and cell viability after MXF exposure was measured. Flow cytometric analysis and TUNEL assay was used to detect apoptotic HCECs after MXF exposure. Ultrastructure of damaged HCECs by MXF was imaged by transmission electron microscope. Western blot analysis and caspase 2, 3 and 8 analysis were used to reveal the underlying mechanism of MXF induced damage in HCECs. We found that MXF induced dose-dependent cytotoxicity in HCECs. MXF exposure increased ROS generation and induced autophagy in HCECs. Increased LDH release represented the cellular membrane damage by MXF. In addition, caspases activation, Bax/Bcl-xL-dependent apoptosis pathway and apoptosis inducing factor nuclear translocation were all involved in MXF induced HCECs' damage, especially after exposure to high dose of MXF (0.5 and 1.0 mg/ml). These findings suggest that MXF toxicity on HCECs should be thoroughly considered by ophthalmologists when intracameral injection of MXF is planned.

Citing Articles

Research progress on the impact of cataract surgery on corneal endothelial cells.

Yang C, An Q, Zhou H, Ge H Adv Ophthalmol Pract Res. 2024; 4(4):194-201.

PMID: 39319216 PMC: 11421245. DOI: 10.1016/j.aopr.2024.08.002.


HPLC analysis, genotoxic and antioxidant potential of Achillea millefolium L. and Chaerophyllum villosum Wall ex. Dc.

Adil M, Dastagir G, Quddoos A, Naseer M, Filimban F BMC Complement Med Ther. 2024; 24(1):91.

PMID: 38365652 PMC: 10870592. DOI: 10.1186/s12906-024-04344-1.


Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery.

Galvis V, Prada A, Tello A, Parra M, Camacho P, Polit M Graefes Arch Clin Exp Ophthalmol. 2023; 261(11):3215-3221.

PMID: 37227478 PMC: 10587335. DOI: 10.1007/s00417-023-06095-0.


Autophagy in the normal and diseased cornea.

Dias-Teixeira K, Sharifian Gh M, Romano J, Norouzi F, Laurie G Exp Eye Res. 2022; 225:109274.

PMID: 36252655 PMC: 10083687. DOI: 10.1016/j.exer.2022.109274.

References
1.
Miller D . Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clin Ophthalmol. 2009; 2(1):77-91. PMC: 2698721. DOI: 10.2147/opth.s1666. View

2.
Haripriya A, Chang D, Ravindran R . Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. Ophthalmology. 2017; 124(6):768-775. DOI: 10.1016/j.ophtha.2017.01.026. View

3.
Lane S, Osher R, Masket S, Belani S . Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg. 2008; 34(9):1451-9. DOI: 10.1016/j.jcrs.2008.05.034. View

4.
Joyce N . Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003; 22(3):359-89. DOI: 10.1016/s1350-9462(02)00065-4. View

5.
Ayaki M, Taguchi Y, Soda M, Yaguchi S, Iwasawa A, Koide R . Cytotoxicity of topical medications used for infection and inflammation control after cataract surgery in cultured corneal endothelial cells. Biocontrol Sci. 2010; 15(3):97-102. DOI: 10.4265/bio.15.97. View